NX
NEXGEL, Inc.
NXGLW · NASDAQ
$0.01 +0.72% (+$0.00)
1M -2.80%
Market Cap $1.01M
P/E Ratio -
Div. Yield -
ROE 133.10%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.20x
P/S 0.08x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 16.42%
Rev. growth 77.33%
FCF growth N/A
Profitability
14 /100
Weak Net margin 51.26%
Op. margin 44.77%
FCF margin 27.10%
Quality
6 /100
Poor ROE 133.10%
ROA 23.39%
Asset turnover 0.46x
Debt
17 /100
High Current ratio 0.43x
Int. coverage -1.73x
Debt/Equity 1.49x
Stability
56 /100
Moderate Rev. volatility 43.55%
EPS volatility 11.74%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NXGLW
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Brian J. Kieser
Employees
19
Headquarters
Langhorne
Upcoming events
17 NOV
Earnings
Upcoming earnings report